Condition
Advanced Malignant Mesothelioma|Extensive Stage Small Cell Lung Cancer|Lung Metastases|Recurrent Malignant Mesothelioma|Recurrent Non-small Cell Lung Cancer|Recurrent Small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer
Estimated Enrollment: 0
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: CCCWFU 62210|NCI-2011-00319
Study First Received: March 28, 2011
Last Updated: January 17, 2017
Estimated Primary Completion Date: March 2013
Primary Outcome Measures:
Safety of interventional cryoablation to the lung|Local control measured by imaging|Changes in Physical function and quality of life|Changes in pulmonary function|Obtain pilot data useful for the design of a subsequent phase II or randomized phase II trial
Sponsors and Collaborators:
Wake Forest University Health Sciences
Website Link: https://ClinicalTrials.gov/show/NCT01325753
